{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T04:36:43Z","timestamp":1769315803249,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1007\/s11926-004-0043-y","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T13:54:14Z","timestamp":1180792454000},"page":"306-313","source":"Crossref","is-referenced-by-count":18,"title":["Common clinical features and disease mechanisms of psoriasis and psoriatic arthritis"],"prefix":"10.1007","volume":"6","author":[{"given":"Wendy","family":"Myers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mobolaji","family":"Opeola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"43_CR1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(03)12954-6","volume":"361","author":"M Lebwohl","year":"2003","unstructured":"Lebwohl M: Psoriasis. Lancet 2003, 361:1197\u20131204.","journal-title":"Lancet"},{"key":"43_CR2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0190-9622(83)80151-0","volume":"9","author":"DM Buntin","year":"1983","unstructured":"Buntin DM, Skinner RB Jr., Rosenberg EW: Onset of psoriasis at age 108. J Am Acad Dermatol 1983, 9:276\u2013277.","journal-title":"J Am Acad Dermatol"},{"key":"43_CR3","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1067\/mjd.2002.120470","volume":"46","author":"C Ferrandiz","year":"2002","unstructured":"Ferrandiz C, Pujol RM, Garcia-Patos V, et al.: Psoriasis of early and late onset: A clinical and epidemiologic study from Spain. J Am Acad Dermatol 2002, 46:867\u2013873.","journal-title":"J Am Acad Dermatol"},{"key":"43_CR4","first-page":"3","volume-title":"Psoriasis","author":"HH Roenigk","year":"1991","unstructured":"Roenigk HH: Skin manifestations of psoriasis. In Psoriasis. Edited by Roenigk HH, Maibach HI. New York: Marcel Dekker, Inc; 1991:3\u20139."},{"key":"43_CR5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-4362.2003.01449.x","volume":"42","author":"H Galadari","year":"2003","unstructured":"Galadari H, Fuchs B, Lebwohl M: Newly available treatments for psoriatic arthritis and their impact on skin psoriasis. Int J Dermatol 2003, 42:231\u2013237.","journal-title":"Int J Dermatol"},{"key":"43_CR6","first-page":"515","volume-title":"Dermatology in General Medicine","author":"R Winchester","year":"1993","unstructured":"Winchester R: Psoriatic arthritis. In Dermatology in General Medicine. Edited by Fitzpatrick T, Gisen A, Wolff K, Freedberg I, Austen K. New York: McGraw-Hill, Inc.; 1993:515\u2013527."},{"key":"43_CR7","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.2165\/00003495-200262170-00004","volume":"62","author":"J Brockbank","year":"2002","unstructured":"Brockbank J, Gladman D: Diagnosis and management of psoriatic arthritis. Drugs 2002, 62:2447\u20132457.","journal-title":"Drugs"},{"key":"43_CR8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1468-3083.2000.00134.x","volume":"14","author":"MA Gupta","year":"2000","unstructured":"Gupta MA, Gupta AK: Quality of life of psoriasis patients. J Eur Acad Dermatol Venereol 2000, 14:241\u2013242.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"43_CR9","first-page":"489","volume-title":"Dermatology in General Medicine","author":"E Christophers","year":"1993","unstructured":"Christophers E, Sterry W: Epidermis: disorders of cell kinetics and differentiation. In Dermatology in General Medicine. Edited by Fitzpatrick T, Gisen A, Wolff K, Freedberg I, Austen K. New York: McGraw-Hill, Inc.; 1993:489\u2013512."},{"key":"43_CR10","volume-title":"Andrew\u2019s Diseases of Skin: Clinical Dermatology","author":"H Arnold","year":"1990","unstructured":"Arnold H, Odom B, James W: Andrew\u2019s Diseases of Skin: Clinical Dermatology. Philadelphia: W.B. Saunders Company; 1990."},{"key":"43_CR11","first-page":"29","volume":"51","author":"EM Farber","year":"1993","unstructured":"Farber EM, Nall L: Pustular psoriasis. Cutis 1993, 51:29\u201332.","journal-title":"Cutis"},{"key":"43_CR12","unstructured":"National Psoriasis Foundation. www.psoriasis.org. Accessed September 19, 2003."},{"key":"43_CR13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00128071-200102030-00005","volume":"2","author":"PC Kerkhof van de","year":"2001","unstructured":"van de Kerkhof PC, Franssen ME: Psoriasis of the scalp: diagnosis and management. Am J Clin Dermatol 2001, 2:159\u2013165.","journal-title":"Am J Clin Dermatol"},{"key":"43_CR14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2133.2001.04046.x","volume":"144","author":"SE Cockayne","year":"2001","unstructured":"Cockayne SE, Messenger AG: Familial scarring alopecia associated with scalp psoriasis. Br J Dermatol 2001, 144:425\u2013427.","journal-title":"Br J Dermatol"},{"key":"43_CR15","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1365-2133.2001.04505.x","volume":"145","author":"RJ Chalmers","year":"2001","unstructured":"Chalmers RJ, O\u2019Sullivan T, Owen CM, Griffiths CE: A systematic review of treatments for guttate psoriasis. Br J Dermatol 2001, 145:891\u2013894.","journal-title":"Br J Dermatol"},{"key":"43_CR16","volume-title":"Color Atlas and Synopsis of Clinical Dermatology-Common and Serious Diseases","author":"TB Fitzpatrick","year":"1997","unstructured":"Fitzpatrick TB, Johnson RA, Wollf K, et al.: Color Atlas and Synopsis of Clinical Dermatology-Common and Serious Diseases. New York: McGraw-Hill; 1997."},{"key":"43_CR17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0095-4543(05)70202-5","volume":"27","author":"GS Drew","year":"2000","unstructured":"Drew GS: Dermatology-psoriasis. Prim Care 2000, 27:385\u2013406.","journal-title":"Prim Care"},{"key":"43_CR18","doi-asserted-by":"crossref","DOI":"10.1201\/b14220","volume-title":"Therapy of Moderate-to-Severe Psoriasis","author":"GD Weinstein","year":"2003","unstructured":"Weinstein GD, Gottlieb AB: Therapy of Moderate-to-Severe Psoriasis. New York: Marcel Dekker, Inc.; 2003. Up-to-date reviews of available traditional and biologic therapies."},{"key":"43_CR19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ajhp\/57.7.645","volume":"57","author":"BP Peters","year":"2000","unstructured":"Peters BP, Weissman FG, Maka G: Pathophysiology and treatment of psoriasis. Am J Health Syst Pharm 2000, 57:645\u2013662.","journal-title":"Am J Health Syst Pharm"},{"key":"43_CR20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0190-9622(96)90078-X","volume":"34","author":"MS Green","year":"1996","unstructured":"Green MS, Prystowsky JH, Cohen SR: Infectious complications of erythrodermic psoriasis. J Am Acad Dermatol 1996, 34:911\u2013914.","journal-title":"J Am Acad Dermatol"},{"key":"43_CR21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/00015550260132488","volume":"82","author":"B Kumar","year":"2002","unstructured":"Kumar B, Saraswat A, Kaur I: Palmoplantar lesions in psoriasis: a study of 3065 patients. Acta Derm Venereol 2002, 82:192\u2013195.","journal-title":"Acta Derm Venereol"},{"key":"43_CR22","first-page":"260","volume":"3","author":"AB Gottlieb","year":"2003","unstructured":"Gottlieb AB, Chaudhari U, Baker DG, et al.: The national psoriasis score (NPF-PS) system versus the psoriasis area severity index and physician\u2019s global assessment (PGA): a comparison. J Drugs Dermatol 2003, 3:260\u2013266.","journal-title":"J Drugs Dermatol"},{"key":"43_CR23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1067\/mjd.2000.106374","volume":"43","author":"JG Krueger","year":"2000","unstructured":"Krueger JG, Feldman SR, Camisa C, et al.: Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis. J Am Acad Dermatol 2000, 43:281\u2013285. This article outlines the importance of quality of life in assessment psoriasis severity","journal-title":"J Am Acad Dermatol"},{"key":"43_CR24","first-page":"974","volume-title":"Textbook of Rheumatology","author":"CJ Michet","year":"1993","unstructured":"Michet CJ: Psoriatic arthritis. In Textbook of Rheumatology. Edited by Kelley WN, Harris ED, Ruddy S, Sledge CB. Philadelphia: W.B. Saunders Company; 1993:974\u2013984."},{"key":"43_CR25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0733-8635(05)70306-5","volume":"19","author":"AB Gottlieb","year":"2001","unstructured":"Gottlieb AB: Psoriasis-immunopathology and immunomodulation. Dermatol Clin 2001, 19:649\u2013657.","journal-title":"Dermatol Clin"},{"key":"43_CR26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1056\/NEJM200107263450410","volume":"345","author":"RD Granstein","year":"2001","unstructured":"Granstein RD: New treatments for psoriasis. N Engl J Med 2001, 345:284\u2013287.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"43_CR27","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/S0190-9622(03)01134-4","volume":"49","author":"SL Mehlis","year":"2003","unstructured":"Mehlis SL, Gordon KB: The immunology of psoriasis and biologic immunotherapy. J Am Acad Dermatol 2003, 49(Suppl 2):S44-S50.","journal-title":"J Am Acad Dermatol"},{"key":"43_CR28","first-page":"1104","volume":"135","author":"BJ Nickoloff","year":"1999","unstructured":"Nickoloff BJ: The immunologic and genetic basis of psoriasis. Arch Dermatol 1999, 135:1104\u20131110.","journal-title":"Arch Dermatol"},{"key":"43_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.120568","volume":"46","author":"JG Kreuger","year":"2002","unstructured":"Kreuger JG: The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 2002, 46:1\u201323.","journal-title":"J Am Acad Dermatol"},{"key":"43_CR30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2230.2001.00792.x","volume":"26","author":"U Fearon","year":"2001","unstructured":"Fearon U, Veale DJ: Pathogenesis of psoriatic arthritis. Clin Exp Dermatol 2001, 26:333\u2013337.","journal-title":"Clin Exp Dermatol"},{"key":"43_CR31","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI200316069","volume":"111","author":"CT Ritchlin","year":"2003","unstructured":"Ritchlin CT, Haas-Smith SA, Li P, et al.: Mechanisms of TNF-a and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 2003, 111:821\u2013831.","journal-title":"J Clin Invest"},{"key":"43_CR32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/clim.2002.5289","volume":"105","author":"AB Gottlieb","year":"2002","unstructured":"Gottlieb AB, Bos JD: Recombinantly engineered human proteins: transforming the treatment of psoriasis. Clin Immunol 2002, 105:105\u2013116.","journal-title":"Clin Immunol"},{"key":"43_CR33","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/archderm.138.5.591","volume":"138","author":"AB Gottlieb","year":"2002","unstructured":"Gottlieb AB, Krueger JG, Wittkowski K, et al.: Psoriasis as a model for T-cell mediated disease-immunobiologic and clinical effects of treatment with multiple doses of Efalizamab, an anti-CD11a antibody. Arch Dermatol 2002, 138:591\u2013600.","journal-title":"Arch Dermatol"},{"key":"43_CR34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archderm.138.5.657","volume":"138","author":"P Singri","year":"2002","unstructured":"Singri P, West DP, Gordon KB: Biologic therapy for psoriasis: the new therapeutic frontier. Arch Dermatol 2002, 138:657\u2013663.","journal-title":"Arch Dermatol"},{"key":"43_CR35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1067\/mjd.2003.10","volume":"48","author":"AB Gottlieb","year":"2003","unstructured":"Gottlieb AB, Masad S, Ramamurthi R, et al.: Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor alpha monoclonal antibody (infliximab) treatments of moderate to severe psoriasis vulgaris. J Am Acad Dermatol 2003, 48:68\u201375.","journal-title":"J Am Acad Dermatol"},{"key":"43_CR36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1046\/j.1365-4362.2002.01662.x","volume":"41","author":"D Mehrabi","year":"2002","unstructured":"Mehrabi D, Dicarlo JB, Soon SL, McCall CO: Advances in the management of psoriasis: monoclonal antibody therapies. Int J Dermatol 2002, 41:827\u2013835.","journal-title":"Int J Dermatol"},{"key":"43_CR37","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(00)04954-0","volume":"357","author":"U Chaudhari","year":"2001","unstructured":"Chaudhari U, Romano P, Mulcahy LD, et al.: Infliximab monotherapy in the treatment of plaque-type psoriasis. Lancet 2001, 357:1842\u20131847. First, double blind, placebo controlled trial of infliximab monotherapy for psoriasis.","journal-title":"Lancet"},{"key":"43_CR38","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","volume":"349","author":"C Leonardi","year":"2003","unstructured":"Leonardi C, Powers JL, Matheson RT, et al.: Etanercept as monotherapy in patients with psoriasis. N Engl J Med 2003, 349:2014\u20132022.","journal-title":"N Engl J Med"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-004-0043-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-004-0043-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-004-0043-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:47:14Z","timestamp":1559436434000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-004-0043-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["43"],"URL":"https:\/\/doi.org\/10.1007\/s11926-004-0043-y","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}